Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2025-12-25 @ 2:14 PM
NCT ID:
NCT02988466
Group ID:
EG003
Title:
Arm D: Haplo-HCT Aged ≥65 and ≤75yo OR Any Age HCT-CI ≥3
Description:
Reduced-intensity conditioning and transplantation of human leukocyte antigen (HLA) -haploidentical related donor stem cells for patients patients ≥65 and ≤75 years old OR any age group with hematopoietic cell transplantation Comorbidity Index (HCT-CI) ≥3.
GVHD Prophylaxis: - Cyclophosphamide (Cy)
* Tacrolimus (Tac)
* Mycophenolate mofetil (MMF)
Haplo HCT ≥65 and ≤75 years old: - Fludarabine (Flu)
* Cyclophosphamide (Cy)
* Total body irradiation (TBI)
Deaths Number Affected:
18
Deaths Number At Risk:
None
Serious Number Affected:
11
Serious Number At Risk:
35
Other Number Affected:
15
Other Number At Risk:
35
Study:
NCT02988466
Results Section:
NCT02988466
Adverse Events Module:
NCT02988466